California Public Employees Retirement System Gossamer Bio, Inc. Transaction History

California Public Employees Retirement System

$147 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$8.0 - $9.75 $921,600 - $1.12 Million	-115,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$8.63 - $10.94 $91,529 - $116,029	-10,606 Reduced 8.43%	115,200 $1.07 Million
Q4 2020 Feb 02, 2021	SELL	$8.3 - $13.59 $19,920 - $32,616	-2,400 Reduced 1.87%	125,806 $1.22 Million
Q3 2020 Nov 05, 2020	BUY	$11.3 - $14.75 $315,337 - $411,613	27,906 Added 27.82%	128,206 $1.59 Million
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $46,429 - $77,934	4,877 Added 5.11%	100,300 $1.3 Million
Q1 2020 May 12, 2020	BUY	$8.0 - $15.48 $107,200 - $207,432	13,400 Added 16.34%	95,423 $969,000
Q4 2019 Jan 27, 2020	BUY	$14.82 - $26.79 $884,754 - $1.6 Million	59,700 Added 267.44%	82,023 $1.28 Million
Q3 2019 Oct 31, 2019	BUY	$16.02 - $22.47 $194,883 - $273,347	12,165 Added 119.76%	22,323 $375,000
Q2 2019 Aug 15, 2019	BUY	$16.12 - $22.89 $163,746 - $232,516	10,158 New	10,158 $225,000

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

163M

Call Options Held

821K

Put Options Held

557K

Octagon Capital Advisors LP New York, NY

18.4M
Shares

$25.7 Million
3.68% of portfolio
Nea Management Company, LLC Timonium, MD

18.1M
Shares

$25.3 Million
1.16% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$14 Million
0.0% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

8.81M
Shares

$12.3 Million
0.03% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$11.3 Million
4.56% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $132M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account